Abstract
Sarcoidosis is a multisystem granulomatous disorder that causes significant morbidity. Genetic factors contribute to sarcoidosis risks. In this study, we investigated whether copy number variations (CNVs) of FCGR3A (coding for FcγRIIIA) and FCGR3B (coding for FcγRIIIB) genes are associated with sarcoidosis susceptibility and whether the expressions of FcγRIIIA on NK cells and FcγRIIIB on neutrophils are altered in sarcoidosis patients. TaqMan real-time PCR assays were used to analyze the CNV of FCGR3A and FCGR3B genes. FCGR3A and FCGR3B CNV genotypes were compared between 671 biopsy-proven sarcoidosis patients and the same number of healthy controls matched with age, sex, race, and geographic area from the ACCESS (A Case Control Etiologic Study of Sarcoidosis) cohort. Flow cytometry analyses were used to determine expressions of FcγRIIIA on NK cells and FcγRIIIB on neutrophils in phenotype analyses. We found that FCGR3A CNVs were significantly associated with sarcoidosis in females (CN = 1 vs. CN = 2 logistic regression adjusted for sex and race, OR 4.0156, SE = 2.2784, P = 0.0143; CN = 3 vs. CN = 2 logistic regression adjusted for sex and race, OR 2.8044, SE = 1.1065, P = 0.0090), suggesting that FCGR3A gene abnormality influences sarcoidosis development in a gender-specific manner. Furthermore, FcγRIIIA expressions were significantly decreased on NK cells from sarcoidosis patients compared to those from healthy controls (P = 0.0007). Additionally, low FCGR3B CN was associated with sarcoidosis (CN <2 vs. CN = 2 logistic regression adjusted for sex and race, OR 1.5025, SE = 0.2682, P = 0.0226), indicating that the functions of FCGR3B gene may also contribute to the pathogenesis of sarcoidosis. We conclude that FCGR3A CNVs are a major risk factor for female sarcoidosis and FCGR3B CNVs may also affect the development of sarcoidosis.
Similar content being viewed by others
References
Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439:851–855
Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889
Bell DY, Johnson SM, Piantadosi CA (1986) Elevated serum immunoglobulin G levels and bronchoalveolar lymphocytosis as predictors of clinical course in pulmonary sarcoidosis. Ann N Y Acad Sci 465:672–677
Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423. doi:10.1093/humupd/dmi008
Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E, de Haas M, de Boer M, Roos D, Kuijpers TW (2009) Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 30:E640–E650. doi:10.1002/humu.20997
Chatham W (2010) Rheumatic manifestations of systemic disease: sarcoidosis. Curr Opin Rheumatol 22:85–90. doi:10.1097/BOR.0b013e328333ba74
Chen JY, Wang CM, Chang SW, Cheng CH, Wu YJ, Lin JC, Yang B, Ho HH, Wu J (2014) Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients. Arthritis Rheumatol 66:3113–3121. doi:10.1002/art.38813
Coxon A, Cullere X, Knight S, Sethi S, Wakelin MW, Stavrakis G, Luscinskas FW, Mayadas TN (2001) Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity 14:693–704
Daniele RP, McMillan LJ, Dauber JH, Rossman MD (1978) Immune complexes in sarcoidosis: a correlation with activity and duration of disease. Chest 74:261–264
Dubaniewicz A (2010) Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun Rev 9:419–424. doi:10.1016/j.autrev.2009.11.015
Dubaniewicz A (2013) Microbial and human heat shock proteins as ‘danger signals’ in sarcoidosis. Hum Immunol 74:1550–1558. doi:10.1016/j.humimm.2013.08.275
Dubaniewicz A, Typiak M, Wybieralska M, Szadurska M, Nowakowski S, Staniewicz-Panasik A, Rogoza K, Sternau A, Deeg P, Trzonkowski P (2012) Changed phagocytic activity and pattern of Fcgamma and complement receptors on blood monocytes in sarcoidosis. Hum Immunol 73:788–794. doi:10.1016/j.humimm.2012.05.005
Dubaniewicz A, Holownia A, Kalinowski L, Wybieralska M, Dobrucki IT, Singh M (2013) Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen? Hum Immunol 74:45–51. doi:10.1016/j.humimm.2012.10.007
Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SC, de Smith A, Blakemore AI, Froguel P, Owen CJ, Pearce SH, Teixeira L, Guillevin L, Graham DS, Pusey CD, Cook HT, Vyse TJ, Aitman TJ (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39:721–723
Gerke AK (2014) Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med 20:472–478. doi:10.1097/MCP.0000000000000080
Group (1999) Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group. J Clin Epidemiol 52:1173–1186. doi:10.1016/S0895-4356(99)00142-0
Grunewald J (2008) Genetics of sarcoidosis. Curr Opin Pulm Med 14:434–439. doi:10.1097/MCP.0b013e3283043de7
Harrison D, Phillips JH, Lanier LL (1991) Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol 147:3459–3465
Hedfors E, Norberg R (1974) Evidence for circulating immune complexes in sarcoidosis. Clin Exp Immunol 16:493–496
Heron M, Grutters JC, van Velzen-Blad H, Veltkamp M, Claessen AM, van den Bosch JM (2008) Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis. Chest 134:1001–1008. doi:10.1378/chest.08-0443
Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, Gaede KI, Schurmann M, Muller-Quernheim J, Krawczak M, Rosenstiel P, Schreiber S (2008) Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 40:1103–1106. doi:10.1038/ng.198
Hofmann S, Fischer A, Till A, Muller-Quernheim J, Hasler R, Franke A, Gade KI, Schaarschmidt H, Rosenstiel P, Nebel A, Schurmann M, Nothnagel M, Schreiber S (2011) A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J 38:1127–1135. doi:10.1183/09031936.00001711
Hunninghake GW, Crystal RG (1981) Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest 67:86–92. doi:10.1172/JCI110036
Iannuzzi MC, Rybicki BA (2007) Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc 4:108–116. doi:10.1513/pats.200607-141JG
Iannuzzi MC, Rybicki BA, Maliarik M, Popovich J Jr (1997) Finding disease genes. From cystic fibrosis to sarcoidosis. Thomas A. Neff Lecture. Chest 111:70S–73S
Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF, Hirst K, Judson MA, Kavuru MS, Maliarik MJ, Moller DR, Newman LS, Rabin DL, Rose CS, Rossman MD, Teirstein AS, Rybicki BA (2005) Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 6:509–518. doi:10.1038/sj.gene.6364235
Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153–2165. doi:10.1056/NEJMra071714
Jing Y, Ni Z, Wu J, Higgins L, Markowski TW, Kaufman DS, Walcheck B (2015) Identification of an ADAM17 cleavage region in human CD16 (FcgammaRIII) and the engineering of a non-cleavable version of the receptor in NK cells. PLoS One 10:e0121788. doi:10.1371/journal.pone.0121788
Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr (1999) Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:75–86
Krauss JC, PooH Xue W, Mayo-Bond L, Todd RF 3rd, Petty HR (1994) Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3. J Immunol 153:1769–1777
Lajoie L, Congy-Jolivet N, Bolzec A, Gouilleux-Gruart V, Sicard E, Sung HC, Peiretti F, Moreau T, Vie H, Clemenceau B, Thibault G (2014) ADAM17-mediated shedding of FcgammaRIIIA on human NK cells: identification of the cleavage site and relationship with activation. J Immunol 192:741–751. doi:10.4049/jimmunol.1301024
Lazarus A (2009) Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon 55:649–660. doi:10.1016/j.disamonth.2009.04.008
Lei B, DeLeo FR, Hoe NP, Graham MR, Mackie SM, Cole RL, Liu M, Hill HR, Low DE, Federle MJ, Scott JR, Musser JM (2001) Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med 7:1298–1305. doi:10.1038/nm1201-1298
Li Y, Mair DC, Schuller RM, Li L, Wu J (2015) Genetic mechanism of human neutrophil antigen 2 deficiency and expression variations. PLoS Genet 11:e1005255. doi:10.1371/journal.pgen.1005255
Machado LR, Hardwick RJ, Bowdrey J, Bogle H, Knowles TJ, Sironi M, Hollox EJ (2012) Evolutionary history of copy-number-variable locus for the low-affinity Fcgamma receptor: mutation rate, autoimmune disease, and the legacy of helminth infection. Am J Hum Genet 90:973–985. doi:10.1016/j.ajhg.2012.04.018
McClelland EE, Smith JM (2011) Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz) 59:203–213. doi:10.1007/s00005-011-0124-3
McKinney C, Merriman TR (2012) Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum Mol Genet. doi:10.1093/hmg/dds039
McKinney C, Broen JC, Vonk MC, Beretta L, Hesselstrand R, Hunzelmann N, Riemekasten G, Scorza R, Simeon CP, Fonollosa V, Carreira PE, Ortego-Centeno N, Gonzalez-Gay MA, Airo P, Coenen M, Martin J, Radstake TR, Merriman TR (2012) Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun 13:458–460. doi:10.1038/gene.2012.15
Morgenthau AS, Iannuzzi MC (2011) Recent advances in sarcoidosis. Chest 139:174–182. doi:10.1378/chest.10-0188
Mueller M, Barros P, Witherden AS, Roberts AL, Zhang Z, Schaschl H, Yu CY, Hurles ME, Schaffner C, Floto RA, Game L, Steinberg KM, Wilson RK, Graves TA, Eichler EE, Cook HT, Vyse TJ, Aitman TJ (2013) Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus. Am J Hum Genet 92:28–40. doi:10.1016/j.ajhg.2012.11.013
Nagelkerke SQ, Tacke CE, Breunis WB, Geissler J, Sins JW, Appelhof B, van den Berg TK, de Boer M, Kuijpers TW (2015) Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression. Genes Immun 16:422–429. doi:10.1038/gene.2015.25
Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, Scott JA, Urban BC, Peshu N, Dunstan SJ, Hien TT, Phu NH, Padyukov L, Gunnarsson I, Svenungsson E, Savage CO, Watts RA, Lyons PA, Clayton DG, Smith KG (2010) Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 19:3282–3294. doi:10.1093/hmg/ddq216
Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8:34–47. doi:10.1038/nri2206
Nossent JC, Rischmueller M, Lester S (2012) Low copy number of the Fc-gamma receptor 3B gene FCGR3B is a risk factor for primary Sjogren’s syndrome. J Rheumatol 39:2142–2147. doi:10.3899/jrheum.120294
Okamoto H, Mizuno K, Horio T (2003) Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients. J Dermatol 30:503–509. doi:10.1111/j.1346-8138.2003.tb00424.x
Perussia B, Acuto O, Terhorst C, Faust J, Lazarus R, Fanning V, Trinchieri G (1983a) Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J Immunol 130:2142–2148
Perussia B, Starr S, Abraham S, Fanning V, Trinchieri G (1983b) Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol 130:2133–2141
Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV (1990) Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science 248:732–735
Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275–290
Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290:84–89
Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, Luo X, Cooley S, Verneris M, Walcheck B, Miller J (2013) NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 121:3599–3608. doi:10.1182/blood-2012-04-425397
Rossman MD, Kreider ME (2007) Lesson learned from ACCESS (a case controlled etiologic study of sarcoidosis). Proc Am Thorac Soc 4:453–456. doi:10.1513/pats.200607-138MS
Rossman MD, Chien P, Cassizzi A, Elias JA, Schreiber AD (1986) Increased monocyte Fc(IgG) receptor expression in sarcoidosis. Ann N Y Acad Sci 465:260–267
Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145:234–241
Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, Terrin ML, Moller DR, Barnard J, Baughman RP, DePalo L, Hunninghake G, Johns C, Judson MA, Knatterud GL, McLennan G, Newman LS, Rabin DL, Rose C, Teirstein AS, Weinberger SE, Yeager H, Cherniack R (2001a) Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164:2085–2091
Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J Jr, Chase GA, Iannuzzi MC (2001b) Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 153:188–193
Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC (2005) The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77:491–499. doi:10.1086/444435
Smith G, Brownell I, Sanchez M, Prystowsky S (2008) Advances in the genetics of sarcoidosis. Clin Genet 73:401–412. doi:10.1111/j.1399-0004.2008.00970.x
Stockl J, Majdic O, Pickl WF, Rosenkranz A, Prager E, Gschwantler E, Knapp W (1995) Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules. J Immunol 154:5452–5463
Sverrild A, Backer V, Kyvik KO, Kaprio J, Milman N, Svendsen CB, Thomsen SF (2008) Heredity in sarcoidosis: a registry-based twin study. Thorax 63:894–896. doi:10.1136/thx.2007.094060
Tsuboi N, Asano K, Lauterbach M, Mayadas TN (2008) Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 28:833–846
Typiak MJ, Rebala K, Dudziak M, Dubaniewicz A (2014) Polymorphism of FCGR3A gene in sarcoidosis. Hum Immunol 75:283–288. doi:10.1016/j.humimm.2014.02.011
Typiak M, Rebala K, Dudziak M, Slominski JM, Dubaniewicz A (2016) Polymorphism of FCGR2A, FCGR2C, and FCGR3B genes in the pathogenesis of sarcoidosis. Adv Exp Med Biol. doi:10.1007/5584_2015_193
Weinberg I, Vasiliev L, Gotsman I (2000) Anti-dsDNA antibodies in sarcoidosis. Semin Arthritis Rheum 29:328–331. doi:10.1016/S0049-0172(00)80019-0
Wiernik A, Foley B, Zhang B, Verneris MR, Warlick E, Gleason MK, Ross JA, Luo X, Weisdorf DJ, Walcheck B, Vallera DA, Miller JS (2013) Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res 19:3844–3855. doi:10.1158/1078-0432.CCR-13-0505
Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, Adu D, Jolly EC, Watts R, Lau YL, Morgan AW, Nash G, Smith KG (2008) Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 205:1573–1582
Yoshida T, Okabe H, Ochi Y, Hosoda T, Fujiyama Y, Hosoda S (1991) A case of sarcoidosis with increased CD3+ WT31− CD16+ lymphocytes. Rinsho Byori 39:675–677
Ziegler-Heitbrock L (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81:584–592. doi:10.1189/jlb.0806510
Acknowledgments
This manuscript was prepared using ACCESS Research Materials obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center and does not necessarily reflect the opinions or views of the ACCESS or the NHLBI. We greatly appreciate Memorial Blood Center in Saint Paul for donor recruitment and sample collection. This study was partly supported by National Institute of Health grant HL117652 (Wu) and a grant from University of Minnesota Academic Health Center (Wu). The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no any financial support or other benefits from commercial sources for the work reported on in the manuscript, or any other financial interests that any of the authors may have, which could create a potential conflict of interest with regard to the work.
Rights and permissions
About this article
Cite this article
Wu, J., Li, Y., Guan, W. et al. FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis. Hum Genet 135, 715–725 (2016). https://doi.org/10.1007/s00439-016-1669-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-016-1669-3